The present project aims to develop a biologically and clinically relevant deep neural network-based framework using multi-omics data to identify cancer subtypes and subtype-specific biomarkers. Additionally, it aims to combine AI and network biology to develop a drug response prediction model for precision therapy.
Accessibility Controls